Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency

Novo Nordisk Investigational Site, Vienna

Novo Nordisk Investigational Site, Graz

Novo Nordisk Investigational Site, Zurich

Novo Nordisk Investigational Site, Marseille

Novo Nordisk Investigational Site, Atlanta

Novo Nordisk Investigational Site, Tampa

Novo Nordisk Investigational Site, Montpellier

Novo Nordisk Investigational Site, Vicenza

Novo Nordisk Investigational Site, Braunschweig

Novo Nordisk Investigational Site, Seville

Novo Nordisk Investigational Site, Columbus

Novo Nordisk Investigational Site, Duisburg

Novo Nordisk Investigational Site, Detroit

Novo Nordisk Investigational Site, East Lansing

Novo Nordisk Investigational Site, Petah Tikva

Novo Nordisk Investigational Site, Tel Litwinsky

Novo Nordisk Investigational Site, Bonn

Novo Nordisk Investigational Site, Minneapolis

Novo Nordisk Investigational Site, Oklahoma City

Novo Nordisk Investigational Site, Orange

Novo Nordisk Investigational Site, Le Kremlin-Bicêtre

Novo Nordisk Investigational Site, Seattle

Novo Nordisk Investigational Site, Phoenix

Novo Nordisk Investigational Site, Boston

Novo Nordisk Investigational Site, Klagenfurt

Novo Nordisk Investigational Site, Toronto

Novo Nordisk Investigational Site, Helsinki

Novo Nordisk Investigational Site, Barcelona

Novo Nordisk Investigational Site, Aberdeen

Novo Nordisk Investigational Site, Birmingham

Novo Nordisk Investigational Site, Bradford

Novo Nordisk Investigational Site, Bristol

Novo Nordisk Investigational Site, Liverpool

Novo Nordisk Investigational Site, London

Novo Nordisk Investigational Site, Newcastle upon Tyne